Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

artis.com/">http://www.novartis.com.
References
[1]. Izzo, J et al. A randomized double-blind, multi-center study to evulate the efficacy of the combination of amlodipine and valsartan in hypertensive patients uncontrolled on previous monotherapy. ASH, 2007
[2]. Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
[3]. Diovan Web site. http://www.diovan.com/info/about/about_diovan.jsp. Accessed November 28, 2006.
[4]. Norvasc Web site. http://www.norvasc.com/high-blood-pressure-medicine/about-norvasc.asp?print=true. Accessed November 28, 2006.
[5]. World Heart Federation. http://www.worldheart.org/mission-myths-facts.php. Accessed May 8th 2007.
[6]. Chobanian et al. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42: 12006 - 1251
[7]. Kearney et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223
* Norvasc is a registered trademark of Pfizer Inc.
<
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine

Post Your Comments:
(Date:11/6/2009)... Repossessions and liquidations of... quarter of 2009 declined as compared to similar f...ment,s NasTrac Quarterly Index (NQI). The figures...oth repossessions and orderly liquidations, also i...tion and printing equipment, offering mixed news o...
(Date:11/6/2009)...swire-FirstCall/ -- Caraco Pharmaceutical Laborato...ac tromethamine ophthalmic solution, 0.5% followin...istration (FDA) for Sun Pharma,s Abbreviated New D...hthalmic solution on the first day following paten...eutically equivalent to Acular® Ophthalmic So...
(Date:11/6/2009)...Newswire-USNewswire/ -- America,s Specialty Medici... mid-market and smaller innovator pharmaceutical c..., the "Affordable Health Care for America Act," in...smaller companies fear that the cumulative effect ...heir efforts to bring new medicines to market. ,...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Great Lakes 26apos 3B New Digital Splints Offer Accuracy Predictable Results and Reduced Chair time 54010 1Great Lakes 26apos 3B New Digital Splints Offer Accuracy Predictable Results and Reduced Chair time 54010 2Limb sparing surgery may not provide better quality of life than amputation for bone cancer patients 54006 1Limb sparing surgery may not provide better quality of life than amputation for bone cancer patients 54006 2Tumor suppressor pulls double shift as reprogramming watchdog 9523 1Tumor suppressor pulls double shift as reprogramming watchdog 9523 2Tumor suppressor pulls double shift as reprogramming watchdog 9523 3
...2 at the American Society of Nephrology ...O, Calif., Oct. 16 ,Exelixis, Inc. (Nasdaq: EXEL ...l of XL784 did not meet its primary endpoint of re...ts with proteinuria associated with diabetic,nephr... to assess whether,further evaluation of the compo...
...Texas, Oct. 15 /PRNewswire-FirstCall/,-- Lexicon P...ta regarding,Phase 1 clinical trial results for LX... of Gastroenterology in Philadelphia, Pennsylvania...ly well-tolerated at all dose,levels and that expo...nificant reduction of urinary 5-hydroxyindoleaceti...
Other Medicine Technology:Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 2Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 3Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 4Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome 2Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome 3
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/...merica (PhRMA) Senior Vice President Ken Johnson r...e health care reform bill: ,, "We are disappoin...iness echoed by millions of hardworking Americans ...House of Representatives who voted against the bil...
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/...rry, Director, Operation Rescue Insurrecta Nex. ,...country have been fighting to keep child-killing b... ,, Mr. Terry states: "This is a great first st...-- but we have a lot of fighting ahead of us. Our ...
(Date:11/8/2009)... , Health Care Vote Shows Who Sides With Wor...SBURG, Pa., Nov. 8 On t...se of Representatives for a good, balanced health ...d its scoring of how our state,s U.S. representati...or America Act. ,, The legislation, which pass...
(Date:11/8/2009)... , HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNe... Celebration of Babies luncheon to recognize promi...their children and who are role models for March o.... As part of the March of Dimes November Prematur...ial guests were urged to join the fight for preemi...
(Date:11/7/2009)... , WASHINGTON , Nov. 7 /PRNewswire-USNewswi...oor today in support of H.R. 3962, the Affordable ...on the legislation later tonight. Below are the S... we all know, is an historic moment for our nation... leaders of every party and political philosophy -...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...cals, Inc. (Nasdaq: ISIS ) today announced that i...no Antitrust Improvements Act for its,collaboratio...pany, which,was announced on September 13, 2007. ...25568 and ISIS 377131, which selectively inhibit t...
..., NEW YORK, and MADISON, Wis., Oct. 2 Caxton-Ise...nt firm, announced today that,it has acquired Conn...arketer of personal protective equipment, safety e...n. Founded in 1946, Madison, Wisconsin-based Conn...
...ades of developing highly effective, easy-to-use f...g and introducing them worldwide, the Institute fo...ty Medical Center has been awarded a five-year, $3...ng countries. USAID has been funding the Institute...
...age in the shoulder may lead to lifelong ...GOMERY, Ala., Oct. 1 Hundreds of individuals acro...with the pain that often,follows shoulder surgery....to: http://www.newscom.com/cgi-bin/prnh/20071001/...
...od of time after leaving the foster care system ap...han those with stable housing situations, accordin...Pediatrics & Adolescent Medicine, one of the JAMA/...alth care than those with stable housing situation...
...earch for new Alzheimer,s,drugs, BIRMINGHAM, Ala....r-profit organization that conducts basic and appl...overy and drug development --,today announced it h...iption factor which could lead to the,development ...
Other Medicine News:Health News:Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc. 2Health News:Caxton-Iseman Capital Acquires Conney Safety Products, LLC 2Health News:New USAID grant helps Georgetown meet unmet family planning needs worldwide 2Health News:A New Study Links High Volume Pain Pumps with the Devastating and Painful Loss of Cartilage Following Arthroscopic Shoulder Surgery 2Health News:A New Study Links High Volume Pain Pumps with the Devastating and Painful Loss of Cartilage Following Arthroscopic Shoulder Surgery 3Health News:Poor health care access common among youth leaving foster system 2Health News:Poor health care access common among youth leaving foster system 3Health News:Southern Research Institute's Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding 2Health News:Southern Research Institute's Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding 3
Snap-In Snap-Out®-II Pincers Grasping Forceps Insert
Snap-In Snap-Out®-II Cobra Grasping Forceps Insert
Snap-In Snap-Out®-II Allis Grasping Forceps Insert
Snap-In Snap-Out®-II Claw Grasping Forceps Insert
Medicine Products: